Developing antibodies to fight bacterial infections
Antibody Core
This study is all about making special proteins called antibodies that can help your body fight off bacterial infections, and it aims to create new treatments that could boost your immune system if you're dealing with these kinds of illnesses.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scripps Research Institute, the NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11082426 on NIH RePORTER |
What this research studies
This research focuses on the engineering and production of antibodies that can target and neutralize bacterial infections. It involves creating both polyclonal and monoclonal antibodies through various methods, including immunization of animals and advanced techniques like single B cell antibody chain sequencing. The antibodies produced will be characterized for their effectiveness in binding to specific bacterial antigens, which is crucial for developing new treatments. Patients may benefit from the resulting therapies that could enhance their immune response against bacterial diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from bacterial infections or those at high risk of such infections.
Not a fit: Patients with viral infections or non-infectious diseases may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new antibody-based therapies that improve treatment outcomes for patients with bacterial infections.
How similar studies have performed: Previous research has shown success in developing antibody therapies for bacterial infections, indicating that this approach has potential for meaningful advancements.
Where this research is happening
La Jolla, United States
- Scripps Research Institute, the — La Jolla, United States (Active)
Researchers
- Principal investigator: Teyton, Luc — Scripps Research Institute, the
- Study coordinator: Teyton, Luc
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.